- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05420298
Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects
Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects( Randomized Control Trial)
Spinal pain or misalignment is a very common disorder affecting a significant number of populations resulting in substantial disability and economic burden. Various manual therapeutic techniques such as spinal manipulations and mobilizations can be used to treat and manage pain and movement dysfunctions such as spinal malalignments and associated complications. These manual therapeutic techniques can affect the cardiovascular parameters .
-
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Group A group (n=20). All participants will receive only single session of neck mobilization. Grade IV unilateral posteroanterior pressure and sustained extension to be applied restricted joints and muscle energy technique.
- Group B (n=20) will receive single session of neck manipulation with high-velocity, low-amplitude thrust over restricted joints (one at a time) with the goal of restoring normal range of motion in the joint.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alaa El-Moatasem, lecturer
- Phone Number: 01006625054
- Email: alaamotasem@rocketmail.com
Study Contact Backup
- Name: donia El-Masry, Lecturer
- Phone Number: 01005587119
- Email: egydodo@rocketmail.com
Study Locations
-
-
-
Cairo, Egypt, 11432
- Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- SBP ranging from 135 to 159 mm Hg or DBP ranging from 85 to 99 mm Hg over 3 qualifying BP screening visits
- The age of participants will range from 27 to 60 years old.
- Body mass index of participants will range between < 39 kg/m².
Exclusion Criteria:
- cardiovascular diseases or surgery, including second- or third-degree heart block, angina pectoris, defibrillator, valvular disease, recent myocardial infarction, cardiac surgery in the past 12 months.
- history of stroke.
- body mass index (BMI) greater than 39 kg/m2.
- pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: cervical mobilization
session will include3-5 repetitions of muscle energy technique in combination of facet joint mobilization of unilateral antro-posterior glide and extension repetitions
|
All participants will receive only single session of cervical mobilization
|
Active Comparator: cervical manipulation
patients will receive high velocity low amplitude thrust
|
All participants will receive only single session of cervical manipulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
systolic blood pressure measurement
Time Frame: it will be measured immediately before and after single session treatment
|
systolic pressure - the pressure when your heart pushes blood out and is measured by Mercury sphygmomanometer and stethoscope
|
it will be measured immediately before and after single session treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
diastolic blood pressure
Time Frame: it will be measured immediately before and after single session treatment
|
the pressure when your heart rests between beats is measured by Mercury sphygmomanometer and stethoscope
|
it will be measured immediately before and after single session treatment
|
oxygen saturation
Time Frame: it will be measured immediately before and after single session treatment
|
Oxygen saturation is a vital parameter to define blood oxygen content and oxygen delivery and is measured by pulse oximetry
|
it will be measured immediately before and after single session treatment
|
perfusion index
Time Frame: it will be measured immediately before and after single session treatment
|
Perfusion index is an indication of the pulse strength at the sensor site.
The PI's values range from 0.02% for very weak pulse to 20% for extremely strong pulse.Perfusion index is normally monitored with pulse oximeters
|
it will be measured immediately before and after single session treatment
|
pain assessment
Time Frame: it will be measured immediately before and after single session treatment
|
The visual analog scale (VAS) is a tool widely used to measure pain
|
it will be measured immediately before and after single session treatment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/003253
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on cervical mobilization
-
Riphah International UniversityCompleted
-
Noha ElsertyRecruiting
-
Gazi UniversityCompleted
-
Mücahit ÖZTOPPamukkale UniversityCompleted
-
Universidad Europea de MadridCompleted
-
Shenandoah UniversityCompletedMusculoskeletal Neck Pain | Unilateral HeadacheUnited States
-
Loma Linda UniversityCompleted
-
Hacettepe UniversityCompletedIdiopathic Parkinson's DiseaseTurkey
-
University of LahoreRecruiting
-
Youngstown State UniversityFranklin Pierce UniversityCompletedNeck PainUnited States